Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Human Pathology

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.humpath.2011.08.012PMID 22204709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy

  2010cited by this paper
• Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy

  2008cited by this paper
• Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma

  2008cited by this paper
• High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT–PCR mRNA expression profile

  2007cited by this paper
• Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.

  2007influential reference
• Effect of distributional heterogeneity on the analysis of tumor hypoxia based on carbonic anhydrase IX

  2007cited by this paper
• Evaluation of CD31 (PECAM-1) Expression Using Tissue Microarray in Patients with Renal Cell Carcinoma

  2007influential reference
• CD105 expression is an independent predictor of survival in patients with endometrial cancer.

  2006cited by this paper
• Organ‐specific endoglin (CD105) expression in the angiogenesis of human cancers

  2006cited by this paper
• Endoglin (CD105) expression in human renal cell carcinoma

  2006cited by this paper
• Prognostic significance of microvessel density determined by an anti‐CD105/endoglin monoclonal antibody in astrocytic tumors: Comparison with an anti‐CD31 monoclonal antibody

  2005cited by this paper
• Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.

  2005cited by this paper
• Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens.

  2005influential reference
• Up-regulation of the redox mediators thioredoxin and apurinic/apyrimidinic excision (APE)/Ref-1 in hypoxic microregions of invasive cervical carcinomas, mapped using multispectral, wide-field fluorescence image analysis.

  2004cited by this paper
• Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma

  2004cited by this paper
• Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas.

  2003cited by this paper
• Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer

  2002cited by this paper
• Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.

  2001cited by this paper
• Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma.

  2001cited by this paper
• Tumor angiogenesis: past, present and the near future.

  2000cited by this paper
• Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model.

  2000cited by this paper
• Elevated expression of endoglin, a component of the TGF‐β‐receptor complex, correlates with proliferation of tumor endothelial cells

  1999cited by this paper
• Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.

  1999cited by this paper
• Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using 125I‐labeled anti‐endoglin monoclonal antibodies

  1999cited by this paper
• Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma.

  1998cited by this paper
• Tumor angiogenesis as a prognostic factor in ovarian carcinoma

  1997cited by this paper
• Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.

  1995cited by this paper
• PROGNOSTIC SIGNIFICANCE OF MICROVESSEL COUNT IN LOW STAGE RENAL CELL CARCINOMA

  1995cited by this paper
• Microvessel density in renal cell carcinoma: lack of prognostic significance.

  1995cited by this paper
• Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

  1993cited by this paper
• Prognostic significance of morphologic parameters in renal cell carcinoma

  1982influential reference

• Integrative single-cell transcriptomic and multi-dimensional bioinformatic analysis reveals proliferation-associated gene expression signatures and cellular heterogeneity in hepatocellular carcinoma.

  2026cites this paper
• CD105 in the progression and therapy of renal cell carcinoma.

  2023cites this paper
• Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors?

  2022cites this paper
• Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma

  2022cites this paper
• CD 105/Endoglin is a Challenging Marker of Angiogenesis in Renal Cell Carcinoma with Specific Pattern of Sarcomatoid Component

  2021cites this paper
• Endoglin Expression and Microvessel Density as Prognostic Factors in Pediatric Rhabdomyosarcoma

  2021cites this paper
• Endoglin Expression as a Measure of Microvessel Density in Oral Head and Neck Cancer by Immunohistochemical Study.

  2020cites this paper
• Current updates and future perspectives on the management of renal cell carcinoma.

  2020cites this paper
• CD105 as a tool for assessing microvessel density in renal cell carcinoma

  2019influential citation
• Expression of CK19, CD105 and CD146 are associated with early metastasis in patients with renal cell carcinoma

  2018cites this paper
• Tumoral CD 105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma

  2018cites this paper
• Functional significance of CD105-positive cells in papillary renal cell carcinoma

  2017cites this paper
• Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma

  2017cites this paper
• Platelets: “First Responders” in Cancer Progression and Metastasis

  2017cites this paper
• Evolving Treatment Paradigm in Metastatic Renal Cell Carcinoma.

  2017cites this paper
• Changing landscapes in the treatment of advanced renal cell carcinoma

  2016cites this paper
• Renal Cancer Stem Cells: Characterization and Targeted Therapies

  2016cites this paper
• Heterogeneous vascular patterns in renal cell carcinomas.

  2016cites this paper
• Regulation of transforming growth factor beta (TGFβ) at the level of nuclear entry

  2016cites this paper
• The clinical significance of serum SCC-Ag combined with CD 105 in patients with cervical cancer during the early stage diagnosis

  2016cites this paper
• Next-Generation Pathology — Surveillance of Tumor Microecology asood

  2015cites this paper
• Caveolin-1 is a modulator of clonogenicity in renal cell carcinoma

  2015cites this paper
• Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy

  2015cites this paper
• Biology of renal tumour cancer stem cells applied in medicine

  2015influential citation
• Editorial Comment to Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy

  2015cites this paper
• Next-generation pathology--surveillance of tumor microecology.

  2015cites this paper
• Renal Cell Carcinoma Cancer Stem Cells as Therapeutic Targets

  2014cites this paper
• Serous neoplasms of the pancreas share many, but not all aspects of their microvascular and angiogenic profile with low-grade clear cell renal cell carcinomas.

  2014cites this paper
• Clinical and molecular prognostic and predictive biomarkers in clear cell renal cell cancer.

  2014cites this paper
• Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma

  2014cites this paper
• Expression of Endoglin (CD-105) and Microvessel Density in Oral Dysplasia and Squamous Cell Carcinoma.

  2014cites this paper
• Convergence of Nanotechnology and Cancer Prevention: Are We There Yet?

  2014cites this paper
• Endoglin for Targeted Cancer Treatment

  2014cites this paper
• The expression and characterization of endoglin in uterine leiomyosarcoma

  2013cites this paper
• GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM

  2013cites this paper
• Quantitative Proteomic Analysis in Metastatic Renal Cell Carcinoma Reveals a Unique Set of Proteins with Potential Prognostic Significance*

  2012cites this paper